Final report of Breast Cancer Care Registry at the Kenyatta National Hospital, Nairobi
Othieno-Abinya, Nicholas Anthony, Musibi, Alice, Nyongesa, Catherine, Njihia, Benjamin, Gachii, Andrew, Kiarie, Gladwell Wanjiru Kamere, Nyawira, Beatrice, Onyango, Ochieng' Noel
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Report on breast cancer care (BRECC) registry at the Kenyatta National Hospital, Nairobi, Kenya
Othieno-Abinya, Nicolas Anthony, Musibi, Alice, Nyongesa, Catherine, Omollo, Raymond, Njihia, Benjamin, Nyawira, Beatrice, Onyango, Ochieng' Noel, Gachii, Andrew
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer
Hurvitz, Sara A, Bachelot, Thomas, Bianchini, Giampaolo, Harbeck, Nadia, Loi, Sherene, Park, Yeon Hee, Prat, Aleix, Gilham, Leslie, Boulet, Thomas, Gochitashvili, Nino, Monturus, Estefania, Lambertini, Chiara, Nyawira, Beatrice, Knott, Adam, Restuccia, Eleonora, Schmid, Peter
Published in Future oncology (London, England) (01.10.2022)
Published in Future oncology (London, England) (01.10.2022)
Get full text
Journal Article
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update
Loibl, Sibylle, Jassem, Jacek, Sonnenblick, Amir, Parlier, Damien, Winer, Eric, Bergh, Jonas, Gelber, Richard D, Restuccia, Eleonora, Im, Young-Hyuck, Huang, Chiun-Sheng, Dalenc, Florence, Calvo, Isabel, Procter, Marion, Caballero, Carmela, Clark, Emma, Raimbault, Alice, McConnell, Robin, Monturus, Estefania, de Azambuja, Evandro, Gomez, Henry L, Bliss, Judith, Viale, Giuseppe, Bines, Jose, Piccart, Martine
Published in Journal of clinical oncology (01.11.2024)
Published in Journal of clinical oncology (01.11.2024)
Get full text
Journal Article
Abstract GS03-12: Phase III study of adjuvant ado-trastuzumab emtansine vs trastuzumab for residual invasive HER2-positive early breast cancer after neoadjuvant chemotherapy and HER2-targeted therapy: KATHERINE final IDFS and updated OS analysis
Loibl, Sibylle, Mano, Max, Untch, Michael, Huang, Chiun-Shen, Mamounas, Eleftherios, Wolmark, Norman, Knott, Adam, Siddiqui, Asna, Boulet, Thomas, Nyawira, Beatrice, Restuccia, Eleonora, Geyer, Charles
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PO3-20-01: ASTEFANIA: a Phase III study of ado-trastuzumab emtansine plus atezolizumab or placebo as adjuvant therapy in patients with residual invasive breast cancer after neoadjuvant HER2-targeted therapy and chemotherapy
Schmid, Peter, Bachelot, Thomas, Bianchini, Giampaolo, Harbeck, Nadia, Loi, Sherene, Park, Yeon, Prat, Aleix, Gilham, Leslie, Boulet, Thomas, Gochitashvili, Nino, Monturus, Estefania, Lambertini, Chiara, Nyawira, Beatrice, Knott, Adam, Hurvitz, Sara
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article